Specific binding of 4-hydroxyestradiol to mouse uterine protein: Evidence of a physiological role 4-hydroxyestradiol

Journal of Endocrinology

Volumn 185, Issue 2, 2005, Pages 235-242

  Markides, C S A ^a   Liehr, J G ^a  

^a Stehlin Found for Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; CYTOPLASM PROTEIN; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE BINDING PROTEIN; STEROID HORMONE; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; BRAIN; CONTROLLED STUDY; CYTOSOL; DISSOCIATION CONSTANT; FEMALE; HORMONE ACTION; HORMONE BINDING; INCUBATION TIME; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; STATISTICAL SIGNIFICANCE; UTERUS;

ANIMALS; BINDING, COMPETITIVE; CYTOSOL; ESTRADIOL; FEMALE; LUNG; MICE; PROTEIN BINDING; PROTEINS; RADIOLIGAND ASSAY; UTERUS;

EID: 18844369288     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06014     Document Type: Article

References (35)

1. Abul-Hajj YJ & Cisek PL 1988 Catechol estrogen adducts. Journal of Steroid Biochemistry 31 107-110.
2. Ball P, Emons G, Haupt O & Knuppen R 1983 Pharmacological effects of 2- and 4-methyloestradiol as a probe to test the biological important of 2- 4-hydroxylation of oestrogens (catecholestrogen formation). Acta Endocrinologica 102 150-152.
3. Barnea ER, MacLusky NJ & Naftolin F 1983 Kinetics of catecholestrogen-estrogen receptor dissociation: a possible factor underlying differences in catecholestrogen biological activity. Steroids 41 643-656.
4. Bui QD & Weisz J 1988 Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. Endocrinology 124 1085-1087.
5. Das SK, Taylor JA, Korach KS, Paria BC, Dey SK & Lubhan DB 1997 Estrogenic responses in estrogen receptor-α deficient mice reveal a distinct signaling pathway. PNAS 94 12786-12791.
6. Dehennin L, Blacker C, Reiffsteck A & Scholler R 1984 Estrogen 2-, 4-, 6- or 16-hydroxylation by human follicles shown by gas chromatography-mass spectrometry associated with stable isotope dilution. Journal of Steroid Biochemistry 20 465-471.
7. Emons G, Merriam GR, Pfeiffer D, Loriaux DL, Ball P & Knuppen R 1987 Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male. Journal of Steroid Biochemistry 28 499-504.
8. Foster AB, Jarman M, Leung OT, McCague R, Leclercq G & Devleeschouwer N 1985 Hydroxy derivatives of tamoxifen. Journal of Medicinal Chemistry 28 1491-1497.
9. Gao N, Nester RA & Sarkar MA 2004 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicology and Applied Pharmacology 196 124-135.
10. Gelbke HP, Haupt O & Knuppen R 1973 A simple chemical method for the synthesis of catechol estrogens. Steroids 21 205-218.
11. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ & Sutter TR 1996 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. PNAS 93 9776-9781.
12. Kerlan V, Dreano Y, Bercovici JP, Beaune PH, Floch HH & Berthou F 1992 Nature of cytochrome P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochemical Pharmacology 44 1745-1756.
13. Kirkman H 1959 Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster. National Cancer Institute Monographs 1 1-57.
14. Lee JM, Anderson PC, Padgitt JK, Hanson JM, Waters CM & Johnson JA 2003 Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element. Biochimica et Biophysica Acta 1629 92-101.
15. Liehr JG 2001 Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Human Reproduction Update 7 273-281.
16. Liehr JG & Ricci MJ 1996 4-Hydroxylation of estrogens as marker of human mammary tumors. PNAS 93 3294-3296.
17. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA & Zhu BT 1995 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. PNAS 92 9220-9224.
18. Mondschein JS, Hersey RM, Dey SK, Davis DL & Weisz J 1985 Catecholestrogen formation by pig blastocysts during the preimplantation period: biochemical characterization of estrogen-2/4-hydroxylase and correlation with aromatase activity. Endocrinology 117 2339-2346.
19. Newbold RR & Liehr JG 1999 Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Research 60 235-237.
20. Newbold RR, Bullock BC & McLachlan AJ 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogen. Cancer Research 50 7677-7681.
21. Paria BC, Chakraborty C & Dey SK 1990 Catechol estrogen formation in the mouse uterus and its role in implantation. Molecular and Cellular Endocrinology 69 25-32.
22. Paria BC, Lim H, Wang X-N, Liehr JG, Das SK & Dey SK 1998 Coordination of differential effect of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 139 5235-5246.
23. Philips BJ, Ansell PJ, Newton LG, Harada N, Honda S-I, Ganjam VK, Rottinghaus GE, Welshons WV & Lubahn DB 2004 Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, estrogen receptor-α KO, and aromatase KO mice tissues. Biochemistry 43 6698-6708.
24. Qian X-D & Abul-Hajj YJ 1990 Synthesis and biological activity of 4-methylestradiol. Journal of Steroid Biochemistry 35 745-747.
25. Roy D, Weisz J & Liehr JG 1990 The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. Carcinogenesis 11 459-462.
26. Schütze N, Vollmer G, Wunsche W, Grote A, Feit B & Knuppen R 1994 Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells. Experimental and Clinical Endocrinology 102 399-408.
27. Segaloff A & Gabbard RB 1984 Structure-activity relationships of estrogens: effects of esterification of the 11 beta-hydroxyl group. Steroids 43 111-123.
28. Seeger H, Hadji P & Mueck AO 2003 Endogenous estradiol metabolites stimulate the in vitro proliferation of human osteoblastic cells. International Journal of Clinical Pharmacology and Therapeutics 41 148-152.
29. Shigeta H, Newbold RR, McLachlan JA & Teng C 1996 Estrogenic effect on the expression of estrogen receptor, COUP-TF, and lactoferrin mRNA in developing mouse tissues. Molecular Reproduction and Development 45 21-30.
30. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP & Sutter TR 1996 Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Research 56 2979-2984.
31. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S & Siegfried JM 2002 Human non-small cell lung cancer tumors and cell derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Research 62 2141-2150.
32. Vollmer G, Wunsche W, Schutze N, Feit B & Knuppen R 1991 Methyl and bromo derivatives of estradiol are ligands for the estrogen receptor of MCF-7 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 39 359-366.
33. Weisz J, Bui QD, Roy D & Liehr JG 1993 Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology 131 655-661.
34. Yue W, Santen RJ, Wang JP, Li Y, Verderame ME, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG & Cavalieri EL 2003 Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. Journal of Steroid Biochemistry 86 477-486.
35. Zhu BT & Conney AH 1998 Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 1-27.